Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Intravenous Bisphosphonates for Postmenopausal Osteoporosis



Mottaghi P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2010

Abstract

Numerous clinical studies have shown bisphoshonates (BPs) to be useful and cost-effective options for the fractures prevention and postmenopausal bone loss. The use of oral bisphoshonates is an established option for managment of osteoporosis in postmenopausal women, but many of them complaint from gastrointestinal side effect or frequently dosed oral regimens. To improve upon the suboptimal therapeutic compliance in postmenopausal women, newer, longer-acting intravenous formulations of BPs has been approved for intermittent administration in postmenopausal women.These preparations would become an option for patients who can not tolerate oral BPs or it was ineffective in increasing their bone density. This article proposed to review effectiveness and tolerability of intravenous BPs in postmenopausal women with osteoporosis.
Related Docs
View other Related Docs
1. Comparison of Bone Mineral Density of Osteoporotic and Osteopenia Menopausal Women Treated With Oral Bisphosphonates Before Stopping the Treatment and 1 Year After Drug Holiday Period, Clinical Rheumatology (2024)
2. The Findings of Bone Mineral Densitometry Following Preventive Treatment With Alendronate in Menopausal Women With Osteopenia: What Is the Best Dose?, Journal of Isfahan Medical School (2020)
3. The Role of Dietary Inflammation in the Risk of Osteoporosis in Iranian Postmenopausal Women: A Case-Control Study, Scientific Reports (2025)
4. Pamidronate Infusion Improved Two Cases of Intractable Seronegative Rheumatoid Arthritise, Journal of Research in Medical Sciences (2011)
5. The Prevalence of Osteoporosis/Osteopenia in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
6. Investigating the Prevalence of Osteoporosis Risk Factors in Postmenopausal Women Less Than 65 Years of Age Referring to Al-Zahra Hospital; [بررسی شیوع عوامل خطر پوکی استخوان در زنان یائسه کمتر از ۶۵ سال مراجعه کنندهبه بیمارستان الزهرا (س)], Journal of Isfahan Medical School (2024)
7. The Effect of Alendronate on Lipid Profile of Postmenopausal Women With Osteopenia and Prediabetes: A Randomized Triple-Blind Clinical Trial, Journal of Research in Medical Sciences (2021)
8. The Relationship of Statins Usage and Bone Mineral Density in Postmenopausal Women, Journal of Isfahan Medical School (2014)
Experts (# of related papers)
View all Related Experts
Mansoor Karimifar (5)
Mohammad Reza Salamat (5)
Other Related Docs
9. Relation Between Biochemical Parameters and Bone Density in Postmenopausal Women With Osteoporosis, Advanced Biomedical Research (2023)
10. Alendronate Improves Fasting Plasma Glucose and Insulin Sensitivity, and Decreases Insulin Resistance in Prediabetic Osteopenic Postmenopausal Women: A Randomized Triple-Blind Clinical Trial, Journal of Diabetes Investigation (2019)
11. Acetabular and Sacral Insufficiency Fractures in a Patient With a Long-Term History of Alendronate Consumption; a Case Report, BMC Musculoskeletal Disorders (2023)
12. Bone Health After Bariatric Surgery: Consequences, Prevention, and Treatment, Advanced Biomedical Research (2022)
13. A Study on Bone Mass Density Using Dual Energy X-Ray Absorptiometry: Does High Body Mass Index Have Protective Effect on Bone Density in Obese Patients?, Journal of Research in Medical Sciences (2020)
14. Intravenous Pamidronate for Refractory Rheumatoid Arthritis, Journal of Research in Medical Sciences (2012)
15. Local Single-Dose Teriparatide Administration for Bronj Prevention: Insights From a Rat Model Study, Journal of Maxillofacial and Oral Surgery (2024)
16. Efficacy and Safety of The Biosimilar Denosumab Candidate (Arylia) Compared to the Reference Product (Prolia®) in Postmenopausal Osteoporosis: A Phase Iii, Randomized, Two-Armed, Double-Blind, Parallel, Active-Controlled, and Noninferiority Clinical Trial, Arthritis Research and Therapy (2022)
17. Normative Bone Mineral Density Values in Isfahani Women, Journal of Research in Medical Sciences (2005)
18. Assessment of Bone Mineral Density With Dual Energy X-Ray Absorptiometry in Pre- and Post-Menopausal Women, Iranian Journal of Radiation Research (2008)
19. Relationship of Cardiovascular Diseases and Bone Mineral Density in Postmenopausal Women, Journal of Isfahan Medical School (2014)